Respicardia brings in $33mm through its Series D round
Respicardia Inc. (formerly Cardiac Concepts) raised $33mm through its Series D venture round from 13 undisclosed investors. The company has developed the remede neurostimulation system to treat sleep apnea, thereby improving the health of congestive heart failure patients.
- Medical Devices
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.